The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?

F G Maggs1, J Palace

  • 1University Department of Neurology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK. fgmaggs@doctors.org.uk

Multiple Sclerosis (Houndmills, Basingstoke, England)
|June 30, 2004
PubMed

Insights

The cause of multiple sclerosis (MS) is unclear. This study challenges the idea that MS is primarily inflammatory, proposing that axonal damage might be an independent early event.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) pathogenesis is not fully understood.
  • Key features include inflammation, demyelination, and axonal injury.
  • The primary driver of MS pathology remains debated.

Purpose of the Study:

  • To challenge the prevailing hypothesis of MS as a primary inflammatory condition.
  • To propose an alternative perspective on MS pathogenesis.
  • To investigate the potential for independent axonal damage in MS.

Main Methods:

  • This paper presents a theoretical challenge to existing hypotheses.
  • It involves critical analysis of current evidence on MS pathogenesis.
  • No new experimental data is presented; it is a conceptual review.

Main Results:

  • The study questions the primacy of inflammation in MS initiation.
  • It suggests that axonal damage could be a primary, independent process.
  • This challenges the established view of MS as solely an inflammatory disease.

Conclusions:

  • The primary pathogenic mechanism in MS may not be inflammation.
  • Axonal damage could precede or occur independently of inflammatory processes.
  • Further research is needed to elucidate the initial events in MS pathogenesis.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...